Making the connection between family planning and global sustainability.

WCG is an international non-profit organization committed to empowering, educating and enabling women and girls to make informed choices and access critical reproductive health products and services. WCG’s credentials in product introduction have made it a preferred partner of organizations looking to move products from laboratories and manufacturing plants to the women who need them. WCG excels at forming strategic partnerships to introduce and create access to new contraceptive methods around the world. WCG’s quality and regulatory departments are experienced in the global registration of drugs and devices, and in aiding manufacturers to improve their processes to meet international best practices. We create options for women when it comes to their reproductive health — no matter where they live.


Empower and enable women and girls to make informed choices about their reproductive and sexual health.

Our Leadership

WCG’s senior leadership team & board members share an unwavering commitment to women’s reproductive health information and access. As a woman-led organization, WCG is dedicated to ensuring that women around the world, regardless of location or socio-economic status have access to reproductive health solitions.

Meet the team

Shannon Bledsoe, Executive Director

Shannon Bledsoe is the Executive Director of WCG, an international non-profit organization based in San Diego, CA. She is responsible for leading overall organizational growth and strategic direction, and overseeing the quality of WCG’s programming. Ms. Bledsoe brings nearly 20 years of experience in international development, public health and reproductive rights to this role, leading programs and platforms for both large and small global non-profit organizations. +

In these leadership roles, she has raised nearly $100 million dollars to support the implementation of global programs. She has designed and managed initiatives supporting women’s reproductive health worldwide, and consulted with clients ranging from Yale University to small local organizations on social marketing and addressing barriers to access. Ms. Bledsoe led country platforms in Haiti, Cote d’Ivoire, and the Central African Republic and has worked, lived, and traveled in more than 40 countries. She has an advanced degree from the University of Melbourne, Australia and a BA from the University of California, San Diego.

Kelly Culwell, Chief Medical Officer

Dr. Culwell, the Chief Medical Officer of WCG, is also a Volunteer Assistant Clinical Professor in the Department of Obstetrics and Gynecology at the University of California, Davis and San Diego campuses. She previously served as a Medical officer with the World Health Organization, is widely published in peer reviewed journals and has developed global guidelines for clinical practice during her over 15-year career in women’s health. +

Dr. Culwell received a Bachelor’s of Science from California Lutheran University, a Medical Doctorate from the University of California, Davis and a Masters of Public Health from Northwestern University. She completed her post-graduate training in Obstetrics and Gynecology at University of California San Diego and her Family Planning Fellowship at Northwestern University. She is qualified as a Diplomat from the American Board of Obstetrics and Gynecology.

Wilberto Robles, Sr. Director, Regulatory Affairs

Wilberto has over fifteen years of professional experience in the pharmaceutical, medical device and cosmetic industry with a special focus in reproductive health products. He holds a Bachelor’s of Science in Microbiology and a Master’s in Manufacturing Competitiveness/Industrial Engineering. In 2002, Wilberto joined Wyeth as a Microbiology Scientist where he grew and held managerial positions within the microbiology laboratory and in the Compliance Department. +

Wilberto also worked in other pharmaceutical companies such as Bristol-Myers Squibb, APP Pharmaceuticals and Blu Pharmaceuticals. In these, he expanded his professional experience in Regulatory Affairs, where he held different leadership positions and took hands-on experience with International, EU, LAC and US regulations; Quality Assurance, where he supported the departmental daily activities and several Regulatory Authority inspections; Validation, where he established and improved different processes and equipment; and in Project Management, where he a lead a companywide project for the implementation of a regulatory electronic submissions system and lead due diligence activities for the acquisition of new manufacturing facilities. Mr. Robles has publications in the TOPRA International Journal for Professionals In Regulatory Affairs (Regulatory Rapporteur) and the POLITECHNÊ journal and SHPE (The Official Magazine of the Society of Hispanic Professional Engineers). He is an active member of the Drug Information Association (DIA), Regulatory Affairs Professionals Society (RAPS), and The Organization for Professionals in Regulatory Affairs (TOPRA). Mr. Robles is currently working for WCG as the Senior Director of Regulatory Affairs, in which he expanded his scope and worked on the registrations of drug products, medical devices and cosmetics in more than 120 countries (mostly in Africa, Asia, and Latin America).

Fil Buenviaje, Director, Quality Assurance

Fil Buenviaje has worked in Quality Assurance and Regulatory Affairs for more than 20 years with leadership roles in both the Medical Device and Pharmaceutical industries.   He joined WCG Cares in 2015 and is responsible for ensuring supplier quality, product quality and global regulatory compliance with relevant laws, rules and regulations. This includes Quality Management Systems, Good Manufacturing Practices, Regulatory Compliance, and Post-Market Surveillance. +

Prior to joining WCG Cares, Mr. Buenviaje served in a variety of Quality and Regulatory roles most recently as Director of Quality Assurance at Sequenom Biosciences.  He brings with him extensive experience as a Quality/Regulatory leader supporting development, manufacturing, quality and regulatory activities from his tenure at firms:  Quidel, Biosite, Genzyme Diagnostics and TÜV Product Service.  Mr. Buenviaje has achieved certifications as a European Notified Body Medical Auditor, a Canadian Medical Devices Conformity Assessment Systems (CMDCAS) Qualified Person, ISO 9001 and ISO 13485 Lead Auditor and Regulatory Affairs Certification (RAC-US).  He has also successfully obtained product registrations with U.S., Canada, European, Asia and Latin America regulatory authorities.

James Trussell, PhD - Chair

Dr. James Trussell joined the WCG Board of Directors in December 2016. Dr. Trussell is Professor Emeritus of Economics and Public Affairs and Senior Research Demographer of the Office of Population Research at Princeton University. He is also an Honorary Fellow at the University of Edinburgh. Dr. Trussell is the author or co-author of more than 350 scientific publications, primarily in the areas of reproductive health and demographic methodology. +

His recent research has been focused in 3 areas: emergency contraception, contraceptive failure, and the cost-effectiveness of contraception. Dr. Trussell received his BS in mathematics from Davidson College in 1971, a BPhil in economics from Oxford University in 1973, and a PhD in economics from Princeton University in 1975. He is a Senior Fellow at the Guttmacher Institute and a Deputy Editor at Contraception.

Jill Sheffield

Jill Sheffield is the founder of Women Deliver, an international advocacy organization that convenes global leaders to galvanize action on maternal health and women’s empowerment. Most recently, Ms. Sheffield was one of few civil society representatives appointed to the UN Secretary General’s Commission on Information and Accountability for Women’s and Children’s Health. Ms. Sheffield is the Chair of the FIGO Working Group on Contraception, serves as a Senior External Adviser to the IPPF Governing Council, and is on the Board of PPFA/Global. She is also a consultant/senior adviser to Global Health Strategies on reproductive health and choices.


Ms. Sheffield is also the founder of Family Care International (FCI), a distinguished non-governmental organization and winner of the 2008 United Nations Population Award for outstanding work in sexual and reproductive health and rights. Ms. Sheffield completed advanced degrees at Columbia University, Teachers College, where she was later recognized as a distinguished alumna for her international work in women’s health and education, and she also received the American Public Health Association’s Lifetime Achievement Award in 2008. She was Director of International Programmes at the Carnegie Corporation, and founded FCI in 1987 in response to the call at the Women’s Decade Conference in Nairobi which identified the silent tragedy that one woman dies each minute from pregnancy related causes. Though she has played a central role in several key world conferences, Jill Sheffield believes her true education came in the late 1960s when she worked in Nairobi, Kenya’s Pumwani Hospital in the first family planning/reproductive health outpatient clinic opened in East Africa.


Saundra Pelletier

Saundra Pelletier is the founding CEO of WCG and she also is the CEO of Evofem Biosciences, a clinical-stage biopharmaceutical company committed to developing and commercializing innovative healthcare products to address unmet needs in women’s sexual and reproductive health. Ms. Pelletier has extensive private sector experience in leadership, sales, domestic and international marketing, business development and life cycle management for a variety of women’s healthcare products including contraceptives, vaginal infectives, hormone replacement therapies and fertility treatments.